Concepedia

Jason P. Gardner

JP

Statistics

Publications

28

Citations

4.8K

H-Index

23

Active since

1985

Affiliations

Progenics Pharmaceuticals (United States)(Current)

Albert Einstein College of Medicine

Massachusetts General Hospital

GlaxoSmithKline (United States)

Harvard University

Jason P. Gardner is an author at Progenics Pharmaceuticals (United States) specializing in life sciences, immunology, and infectious diseases.

Publications per year

1985–2017

28

Publications

28

Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy

Alessandra Biffi, Eugenio Montini, Laura Lorioli et al. · Science · 2013 · 1.2K citations · Full text

, , +16

Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome

Alessandro Aiuti, Luca Biasco, Samantha Scaramuzza et al. · Science · 2013 · 1K citations · Full text

, , +16

L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus

Jason P. Gardner, Robert J. Durso, Robert R. Arrigale et al. · Proceedings of the National Academy of Sciences · 2003 · 291 citations · Full text

, , +17

CD81 is an entry coreceptor for hepatitis C virus

Emmanuel Cormier, Fay Tsamis, Francis Kajumo et al. · Proceedings of the National Academy of Sciences · 2004 · 282 citations · Full text

, , +16

The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy

Norbert Schülke, Olga A. Varlamova, Gerald P. Donovan et al. · Proceedings of the National Academy of Sciences · 2003 · 232 citations · Full text

, , +17

1–5 of 28